Next Biometrics soars as Swedish investors buys big stake

OSLO/STOCKHOLM (Reuters) – Norwegian fingerprint sensor maker Next Biometrics said it would raise 120 million Norwegian crowns ($14.78 million) from Greenbridge Partners, a firm founded by Swedish investors Melker Schorling and Ola Rollen, sending shares soaring. “Greenbridge Partners Ltd has undertaken a thorough process before making the investment decision,” Next said in a statement on Friday. Shares of the Norwegian firm shot up 64 percent at 0417 EDT.
Go to Source

India’s Cipla ties up with Serum Institute to sell vaccines in South Africa

Saxena, CEO of Indian generic drugmaker Cipla, poses for a picture in front of company's logo at their headquarters in MumbaiCipla Ltd, India&;s fourth-largest drugmaker by sales, said on Thursday it had agreed to an exclusive deal with Serum Institute of India to supply vaccines to South Africa, adding a new market to their partnership in India and Europe. Cipla&039;s unit Cipla Medpro, South Africa&039;s third-largest drugs manufacturer, will be responsible for obtaining regulatory approvals and marketing of the vaccines under the deal terms, Cipla said in a statement to exchanges.

Go to Source

DNA research deployed in war on cancer scoops Nobel Prize

Professors Sara Snogerup Linse, Goran K. Hansson and Claes Gustafsson, members of the Nobel Assembly, talk to the media at a news conference at the Royal Swedish Academy in StockholmBy Daniel Dickson and Ben Hirschler STOCKHOLM/LONDON (Reuters) – Three scientists from Sweden, the United States and Turkey won the 2015 Nobel Prize for Chemistry on Wednesday for working out how cells repair damaged DNA, providing new ammunition in the war on cancer. Detailed understanding of DNA damage has helped drive a revolution in cancer treatment as researchers develop new drugs that target specific molecular pathways used by tumor cells to proliferate. Tomas Lindahl, Paul Modrich and Aziz Sancar won the prize for "mechanistic studies of DNA repair".

Go to Source

1 7 8 9 10 11